Details of the Drug

General Information of Drug (ID: DMMIQ20)

Drug Name
Patiromer calcium
Synonyms Patiromer; RLY-5016; Potassium binder (hyperkalemia), Relypsa
Indication
Disease Entry ICD 11 Status REF
Hyperkalemia 5C76 Approved [1]
ADMET Property
Elimination
The drug is excreted via feces []
Cross-matching ID
TTD ID
D0Z2YQ

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Potassium (K) TTB0SC6 NOUNIPROTAC Binder [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT01810939) A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia. U.S. National Institutes of Health.
2 Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial. Eur Heart J. 2011 Apr;32(7):820-8.